| 1-(1-(4-chlorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl)-2-(piperidin-1-yl)ethan-1-one |
IU1-47 |
670270-31-2 |
| CFI-402257 |
CS-2627 |
1610759-22-2 |
| GSK2256294A |
SEH抑制剂(GSK2256294A) |
1142090-23-0 |
| PZ-2891 |
PZ-2891 |
2170608-82-7 |
| Leucettine L41 |
化合物 T24402 |
1112978-84-3 |
| K145 |
1309444-75-4 |
1309444-75-4 |
| CM-4620 |
CS-2907 |
1713240-67-5 |
| MTOR inhibitor |
N-乙基-N'-[4-[5,6,7,8-四氢-4-[(3S)-3-甲基-4-吗啉基]-7-(2-嘧啶基)吡啶并[3,4-D]嘧啶-2-基]苯基]脲 |
1207358-59-5 |
| NRC-2694 |
936446-61-6 |
936446-61-6 |
| 8-Nitrotryptanthrin |
8-NITROTRYPTANTHRIN |
77603-42-0 |
| S1p receptor agonist 1 |
CS-2465 |
1514888-56-2 |
| N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide |
LP-211 |
1052147-86-0 |
| KDM5-IN-1 |
1628210-26-3 |
1628210-26-3 |
| Tat-NR2B9c |
500992-11-0 |
500992-11-0 |
| SYP-5 |
1384268-04-5 |
1384268-04-5 |
| 5H-Benzocycloheptene-8-carboxylic acid, 3,4,6-trihydroxy-2-methoxy-5-oxo-, hexyl ester |
1416324-85-0 |
1416324-85-0 |
| AMZ30 |
CS-2122 |
1313613-09-0 |
| Ca2+ channel agonist 1 |
1402821-24-2 |
1402821-24-2 |
| SodiuM Channel inhibitor 1 |
7-氟-2,3-二氢-3-氧代-2-[2-(2-吡啶基)乙基]-N-[[4-(三氟甲氧基)苯基]甲基]-1H-异吲哚-1-甲酰胺 |
1198117-23-5 |
| PSI7409 |
1015073-42-3 |
1015073-42-3 |
